SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as users report widespread platform outages, potentially linked to Amazon Web Services, sparking frustration and concerns about accessibility during trading. The community is debating the cause of the issues, with some questioning the reliability of the platform and others attributing it to broader internet service disruptions. Despite the technical difficulties, the stock price has shown surprising resilience, leading to discussions about market dynamics and potential manipulation.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to positive news regarding its APU CIM architecture achieving GPU-class AI performance with significantly lower energy consumption, sparking community discussion about potential buyouts and comparisons to other AI and chip companies like NVDA. The community is actively debating whether the stock is primed for a short squeeze and discussing strategies to capture further upside. Some traders express concerns about potential dilution and the company's history, while others focus on the potential for long-term growth in the AI and edge computing sectors.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as analysts debate the achievability of its ambitious long-term growth targets outlined during its Analyst Day, specifically regarding revenue and AI infrastructure spending. The community is actively discussing whether AI infrastructure investments will impact profitability, and some are drawing comparisons to past optimistic guidance from the company. Overall, sentiment appears mixed as investors weigh the potential for future growth against possible short-term financial strain.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune ($REPL) is trending due to news of the FDA accepting the resubmission of its Biologics License Application for RP1, a melanoma treatment, leading to significant price movement and trading volume. Community discussions revolve around updated price targets, the potential for a short squeeze, and collaborations with major pharmaceutical companies. However, some traders express caution, citing the long PDUFA timeline and potential for a pump and dump.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as the company explores rare earth production at its U.S. mining sites, potentially pivoting from steel to strategic minerals. Community members are weighing in on the CEO's vision, buyout possibilities, and the potential impact of this move on debt reduction and shareholder value. Some traders express concerns about the CEO's past performance and the sustainability of the recent surge.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending as investors discuss the implications of new data, with some citing a strong response rate in lung cancer patients from a GenFleet study. While some view the sell-off as an overreaction or manipulation, others question the long-term impact and management's spending. The community is actively debating the data's significance and comparing it to competitors in the KRAS G12D space.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the community anticipates potential benefits from its recent listing on Robinhood. Discussions revolve around whether this listing will act as a catalyst for price appreciation, with some drawing comparisons to Dogecoin's earlier success, while others point to Floki's unique utility and deflationary mechanisms.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending due to a significant AWS outage impacting numerous websites and services, sparking concerns about the company's reliability and the internet's dependency on its cloud infrastructure. While some traders anticipate a dip due to potential customer refunds and reputational damage, others see the event as a reminder of AWS's central role in the digital economy, viewing it as a buying opportunity. Community discussions revolve around the outage's impact on various sectors and whether it will affect Amazon's upcoming earnings.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PDI is experiencing volatility, driven by a recent downgrade and discussions around its premium to NAV and dividend coverage amid higher interest rates, sparking community debate on whether to buy the dip or brace for further declines. Community members are actively debating whether this dip represents a buying opportunity or signals deeper problems within the fund, with some citing attractive monthly payouts and high yield. The fund's reliance on leverage and high-yield credit in a challenging rate environment adds to the uncertainty.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance Corp. is trending amid discussions around potential layoffs following the merger, with the community closely monitoring the stock's performance and potential acquisitions, particularly of Warner Bros. Discovery (WBD). Community talking points include speculation about a possible bidding war for WBD and the impact of key personnel appointments within Paramount. Despite some analyst skepticism, optimism persists regarding the company's long-term potential, driven by content IP and restructuring.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>GRAIL plans to raise about $325 million through a private placement involving both new and existing institutional investors.</li><li>The deal includes issuing over 4.6 million shares at $70.05 each, with closing expected on Oct. 21, 2025.</li><li>The funds will support commercial expansion, reimbursement initiatives, and general corporate purposes. &nbsp;</li></ul>GRAIL, Inc. (GRAL) announced on Monday that it has entered into a securities purchase agreement for a private placement to bring in approximately $325 million in gross proceeds to support its growth and commercialization efforts.As part of the deal, the company will issue 4.6 million shares of common stock, or pre-funded warrants, at $70.05 per share. Each pre-funded warrant carries a nominal exercise price of $0.001.<a href="https://stocktwits.com/symbol/GRAL">GRAIL stock</a> traded over 12% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Institutional Investors Back Private Placement</h2>The healthcare company’s agreement involves both fresh and existing institutional backers. The company expects the deal to close on Oct. 21, 2025, pending customary closing requirements.&nbsp;<h2 class="st-heading-2">Funding Expected To Extend Operations Through 2030</h2>GRAIL intends to use the net proceeds toward commercial expansion, reimbursement initiatives, and day-to-day operational needs. This fresh injection of capital, combined with $127.4 million in cash and equivalents as of June end, is projected to sustain its planned operations well into 2030.&nbsp;This forecast does not include a separate $110 million investment agreement from Samsung C&amp;T and Samsung Electronics.Additionally, GRAIL and the University of Oxford released updated registry results from the SYMPLIFY study, which monitored more than 6,000 individuals over two years. The study evaluated a multi-cancer early detection (MCED) test called Galleri in primary care settings.&nbsp;The test’s positive predictive value (PPV) stood at 75.5%, with its ability to accurately pinpoint the Cancer Signal Origin (CSO) in 84.8% of cases.GRAIL stock traded over 336% in 205 and over 438% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-s-i-phone-17-sales-off-to-robust-start-report/ch6ClGMR3oY">Apple’s iPhone 17 Sales Off To Robust Start In Key Markets With Momentum Continuing Into October: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Is GRAL Stock Rising Today?

GRAIL plans to raise about $325 million through a private placement involving both new and existing institutional investors.

Equity

GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings GRAIL PATHFINDER 2...

Precision Oncology Approaches Drive $312B Market Transformation

Precision Oncology Approaches Drive $312B Market Transformation Precision Oncology Approaches Drive $312B Market Transformation PR Newswire VANCOUVER, Oct. 17, 2025 USA News Group News Commentary...

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri...

BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates

BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -36.36% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates

Femasys (FEMY) delivered earnings and revenue surprises of +11.11% and -48.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of -11.11% and +1.96%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Stock Market News for May 23, 2025

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise...

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

GRAIL to Present at TD Cowen 45th Annual Health Care Conference GRAIL to Present at TD Cowen 45th Annual Health Care Conference PR Newswire MENLO PARK, Calif., Feb. 21, 2025 MENLO PARK, Calif., Feb...

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

GRAL
GRAIL Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GRAL News

GRALGRAIL Inc.